Exscientia PLC

Finance

Nvidia invests $50 million in biotech company Recursion for AI drug discovery

Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners,

Read More
Finance

Artificial intelligence drug hunters are nearing a pivotal stage in their development

Over the next 12 to 18 months, AI-first drug developers will provide updates on early clinical work that will help

Read More